id,patient_info,expected_md5,document_name,gt_Q0,gt_Q1,gt_Q2,gt_Q3,gt_Q4,gt_Q5,gt_Q6,gt_Q7,gt_Q8,gt_expected_md5
Case16126,"The patient is a 6-week-old infant being evaluated for multiple congenital anomalies and BRCA1 and BRCA2 testing has been ordered by a gynecologist. FISH testing was previously performed and was nondiagnostic, the parents are reported to be consanguineous, pre-test counseling has been completed with plans for post-test follow-up with a genetic counselor, and testing will be billed through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf,BRCA1/2,No,Not Specified,No,Not Specified,No,Yes,Not Specified,No,c5c2b854957d06467835e88a963d0c82
Case3494,"The six-week-old infant was referred by the general pediatrician for genetic evaluation because of a congenital abnormality affecting at least one organ system with concern for an evolving complex neurodevelopmental disorder; no prior genetic testing has been performed, and there is a family history of dysmorphic features in a sibling, so whole exome sequencing (WES) is being requested for diagnostic clarification, genetic counseling was declined by the family, and coverage is through Cigna.",ad2eb3a750b767e32ff847032f0e8e03,Cigna_MOL.TS_.235.C_Whole_Exome_Sequencing_Cigna_eff01.01.2025_pub09.20.2024.pdf,WES,Yes,Not Specified,Yes,No,No,Not Specified,81415,No,ad2eb3a750b767e32ff847032f0e8e03
Case3422,"The patient is a 34-year-old referred by oncology for evaluation of congenital choanal atresia and consideration of whole-exome sequencing (WES) to assess for an underlying genetic etiology after a nondiagnostic chromosomal microarray (CMA); the patient has Cigna coverage, has seen a genetic counselor multiple times, and reports a mother who was diagnosed with breast cancer at age 50.",ad2eb3a750b767e32ff847032f0e8e03,Cigna_MOL.TS_.235.C_Whole_Exome_Sequencing_Cigna_eff01.01.2025_pub09.20.2024.pdf,WES,No,Not Specified,Yes,Yes,No,Not Specified,81415,No,ad2eb3a750b767e32ff847032f0e8e03
Case5303,"The 37-year-old patient was referred by neurology for BRCA1 and BRCA2 testing in the setting of a major abnormality affecting at least one organ system and a family history notable for a brother who died suddenly and unexpectedly before age 35; no prior genetic testing has been performed and no pre-test genetic counseling was conducted, and the patient has coverage through UHC.",c69485372670ce1d12aa8f61d83a06fd,United Healthcare_genetic-testing-hereditary-cancer.pdf,BRCA1/2,Yes,Not Specified,No,Not Specified,No,Not Specified,81162,No,c69485372670ce1d12aa8f61d83a06fd
Case1501,"The patient is a 2-year-old child referred by a developmental pediatrician for evaluation of multiple congenital anomalies and ongoing developmental concerns, and prior karyotype testing was nondiagnostic; there is a family history of Long QT syndrome in the mother. Whole exome sequencing (WES) is being ordered to identify an underlying genetic etiology, pre-test genetic counseling has been completed with plans for post-test follow-up, and the family has coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Not Specified,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case4067,"The 5-year-old was referred by a developmental pediatrician for evaluation of significant hypotonia and whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology; prior chromosomal karyotype testing was nondiagnostic, and there is a family history of sudden unexplained death in a paternal uncle before age 35 that raises concern for a heritable disorder, with the family reporting coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Not Specified,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case16487,"The newborn is being evaluated for a high-risk brief resolved unexplained event (BRUE) characterized by recurrent events in the absence of respiratory infection, and whole exome sequencing (WES) has been ordered by the oncologist following nondiagnostic fluorescence in situ hybridization (FISH) testing, the family history is notable for a maternal aunt with a persistent severe immunologic or hematologic disorder, the infant has coverage through UHC, and pre-test counseling was completed with plans for post-test genetic follow-up.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Not Specified,Yes,Yes,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case4196,"The patient is a 10-year-old referred by a cardiologist for evaluation of apparent nonsyndromic developmental delay and intellectual disability, and whole exome sequencing (WES) is being requested as the next diagnostic step; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, and there is a family history of a brother who was diagnosed with moderate to severe intellectual disability in childhood, pre-test genetic counseling has been completed with plans for post-test follow-up, and coverage is through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WES,Yes,Not Specified,Not Specified,Yes,Yes,Yes,Not Specified,Yes,d5e9701c13de1dca302ad0ce45524039
Case11855,"The patient is a 14-year-old being evaluated by a developmental pediatrician for a congenital anomaly affecting a single organ system with concern for an underlying genetic etiology, and chromosomal microarray (CMA) is being ordered to assess for copy number variants associated with developmental disorders; Fragile X testing was previously performed and was nondiagnostic. There is a family history notable for a maternal aunt with triple-negative breast cancer, which was discussed as part of the risk assessment during pre-test counseling. Pre-test counseling was completed with a genetic specialist and plans for post-test follow-up were made, and testing will be pursued with coverage through UHC.",8a7d5f974648c666b635eae9e03277e7,United Healthcare_chromosome-microarray-testing.pdf,CMA,Not Specified,Not Specified,No,Not Specified,No,Not Specified,81228,No,8a7d5f974648c666b635eae9e03277e7
Case5674,"A 9-year-old child with persistent seizures is being evaluated by a general practitioner and has had multiple visits with a genetic counselor; a prior chromosomal microarray (CMA) was nondiagnostic, and the team plans whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome given a family history notable for sudden unexplained death in an uncle before age 35, with testing requested under BCBS_FEP and arrangements for post-test follow-up with genetics.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WES,Yes,Not Specified,Yes,Yes,Yes,No,Not Specified,No,d5e9701c13de1dca302ad0ce45524039
Case15570,"The patient is a 15-year-old being followed by a general pediatrician for Hirschsprung disease and the clinician has requested BRCA1 and BRCA2 testing despite the pediatric gastrointestinal indication. Prior karyotype testing was nondiagnostic and the family history is notable for a mother with bipolar disorder, with no other cancer history documented. There is no documentation of pre-test genetic counseling and the test was ordered with coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf,BRCA1/2,No,Not Specified,No,Not Specified,No,No,Not Specified,No,c5c2b854957d06467835e88a963d0c82
Case17595,"A 3-year-old child with significant hearing and visual impairment diagnosed by 18 years of age is being evaluated with chromosomal microarray (CMA) testing to assess for genomic causes of early-onset sensory impairment and associated developmental risk, and the test was ordered by a gynecologist; there is no prior genetic testing information, family history is notable for an uncle who had moderate to profound intellectual disability diagnosed by age 18, pre-test genetic counseling has been completed with plans for post-test follow-up, and the family has coverage through BCBS_FEP.",8340e5b0ce4959eccfb2cb295edb47f3,BCBS_FEP_20459 Genetic Testing for Developmental.pdf,CMA,Not Specified,Not Specified,No,Not Specified,No,Not Specified,Not Specified,No,8340e5b0ce4959eccfb2cb295edb47f3
Case10363,The patient is a 7-year-old child with a congenital anomaly present since birth who was referred by the general practitioner for whole genome sequencing (WGS) after fluorescence in situ hybridization (FISH) testing was nondiagnostic. The family history is notable for a maternal aunt with pancreatic cancer and the family has coverage through UHC. The patient has been seen multiple times by a genetic counselor for pre-test counseling and plans for post-test follow-up are in place. WGS is being pursued to provide a comprehensive genomic evaluation given the longstanding congenital findings and prior nondiagnostic targeted testing.,4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WGS,Yes,No,Yes,Yes,No,Not Specified,81425,No,4fadf6b3ca9d4d08131cb31365e3aa7d
Case2496,"A prenatal evaluation at 32 weeks' gestation has been requested by a neonatologist for whole exome sequencing (WES) with coverage through UHC because of parental consanguinity and concern for autosomal recessive conditions, there is a reported family history of sudden unexplained death in a sibling before age 35, prior fluorescence in situ hybridization testing was nondiagnostic, and no genetic counseling has been completed, so WES is being pursued to assess risk for potential postnatal outcomes based on fetal imaging and to guide perinatal planning.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Not Specified,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case3223,"The 75-year-old woman was referred by her general practitioner for BRCA1 and BRCA2 testing because her sister had epithelial ovarian cancer, and she has a history of a major congenital cardiac anomaly for which a chromosomal microarray (CMA) was previously performed and reported as nondiagnostic. There is no documentation of pre-test genetic counseling, and she has coverage through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf,BRCA1/2,No,Not Specified,No,Not Specified,Yes,No,Not Specified,No,c5c2b854957d06467835e88a963d0c82
Case15938,"The patient is a one-week-old infant under the care of a neonatologist being evaluated for conjugated hyperbilirubinemia not related to total parenteral nutrition and whole-genome sequencing (WGS) is being considered to identify a potential genetic cholestatic or metabolic etiology; prior karyotype testing was nondiagnostic, there is a family history of a sibling with unexplained developmental regression unrelated to autism or epilepsy, no pretest genetic counseling is documented, and the family has coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WGS,Yes,Yes,Yes,Yes,Yes,Not Specified,81425,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case10917,"The patient is an 8-week-old infant evaluated by a medical geneticist for persistent conjugated hyperbilirubinemia not attributed to total parenteral nutrition-associated cholestasis, and whole exome sequencing (WES) has been ordered to evaluate for an underlying genetic cause; family history is notable for an older sibling with multiple congenital anomalies, and Fragile X testing was previously performed and was nondiagnostic; pre-test counseling was completed with a genetic specialist and the family has coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Yes,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case12834,"The patient is a 16-year-old referred by a developmental pediatrician for evaluation of a complex neurodevelopmental disorder affecting at least one organ system, and chromosomal microarray (CMA) testing has been ordered although the requisition specifies a tumor-type rather than a germline assay; prior Fragile X testing was nondiagnostic. There is a family history notable for a maternal uncle with a movement disorder described as dystonia and ataxia, genetic counseling is not documented in the record, and testing will be billed through Cigna.",49b51c0399e5563339f32a9f24f20641,Cigna_MOL.TS_.344.A_Chromosomal_Microarray_Solid_Tumors_eff01.01.2025_pub09.11.2024_0.pdf,CMA,Not Specified,Not Specified,No,Not Specified,No,Not Specified,81277,No,49b51c0399e5563339f32a9f24f20641
Case12792,"A 12-year-old was referred by a family medicine physician for BRCA1/2 testing in the setting of congenital choanal atresia and a reported growth abnormality in the mother. Prior fluorescent in situ hybridization (FISH) testing was nondiagnostic. Pre-test genetic counseling has been completed and post-test follow-up is planned, and testing will be billed through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf,BRCA1/2,No,Not Specified,No,Not Specified,No,Yes,Not Specified,No,c5c2b854957d06467835e88a963d0c82
Case10529,"The child is a 6-year-old with apparent nonsyndromic developmental delay and intellectual disability who was referred by neurology for genetic evaluation; Fragile X testing was previously performed and was nondiagnostic, and there is a family history of neurologic disease in a maternal uncle with dystonia and ataxia. The family has seen a genetic counselor multiple times and pre-test counseling is complete with plans for post-test follow-up, and whole exome sequencing (WES) is being pursued with coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Yes,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case811,"The patient is a 7-week-old infant referred by the general pediatrician for evaluation of early-onset movement abnormalities characterized by dystonia, ataxia and intermittent hemiplegic episodes concerning for a neuromuscular or movement disorder, and chromosomal microarray (CMA) was previously performed and reported as nondiagnostic; given the clinical presentation and a positive family history in an older sibling with multiple congenital anomalies, whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology, pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, and testing is being ordered with coverage through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WES,Yes,Not Specified,Yes,Yes,Not Specified,Yes,Not Specified,Yes,d5e9701c13de1dca302ad0ce45524039
Case10850,"The patient is a 13-year-old with global developmental delay being evaluated by a developmental pediatrician and whole genome sequencing (WGS) has been ordered to search for an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, there is a family history of an aunt with dysmorphic features, and the family completed pre-test genetic counseling with plans for post-test follow-up, with testing pursued through UHC coverage.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WGS,Yes,Yes,Yes,Yes,Yes,Not Specified,81425,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case22,"An 18-year-old man is undergoing BRCA1/2 testing to evaluate for a possible hereditary predisposition in the setting of high-risk prostate cancer with intraductal/cribriform histology and metastatic disease, with testing ordered by his neurologist; his father also had metastatic high-risk prostate cancer with intraductal/cribriform features. A prior chromosomal microarray (CMA) was nondiagnostic. He completed pre-test counseling and will return for post-test follow-up with a genetic counselor, and the testing is being pursued with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf,BRCA1/2,Yes,Not Specified,Yes,Not Specified,Yes,Yes,Not Specified,Yes,c5c2b854957d06467835e88a963d0c82
Case3677,"She is a 46-year-old woman with a personal history of breast cancer who is undergoing BRCA1/2 testing because of a close relative with pancreatic cancer and multiple other primary solid tumors on the same side of the family; prior chromosomal microarray (CMA) testing was nondiagnostic. The patient was referred by a nurse practitioner and completed pre-test genetic counseling with plans for post-test follow-up, and testing will be billed to UHC. Her family history is notable for a mother with pancreatic cancer and at least two additional affected relatives on the maternal side.",c69485372670ce1d12aa8f61d83a06fd,United Healthcare_genetic-testing-hereditary-cancer.pdf,BRCA1/2,Yes,Not Specified,Yes,Not Specified,Yes,Not Specified,81162,Yes,c69485372670ce1d12aa8f61d83a06fd
Case4512,"The patient is a 21-year-old referred by the primary care physician for evaluation of a major congenital cardiac anomaly present since birth, and whole genome sequencing (WGS) is being pursued to identify a potential genetic etiology; there is a family history of a sibling who experienced a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor, and irregular breathing which raised concern for a heritable predisposition, and no prior genetic testing has been performed, pre-test counseling was completed with a genetic counselor and a post-test visit is planned with testing submitted with coverage through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WGS,No,Not Specified,Yes,No,Yes,Yes,Not Specified,No,d5e9701c13de1dca302ad0ce45524039
Case19905,"The patient is a 3-year-old referred by the developmental pediatrician for evaluation of multiple congenital anomalies and is being considered for whole exome sequencing (WES) with coverage through UHC; prior karyotype testing was nondiagnostic, there is a family history notable for a mother with long QT syndrome, and no genetic counseling has been conducted to date.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Not Specified,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case14226,"A 55-year-old patient is being evaluated by oncology for germline BRCA1 and BRCA2 (BRCA1/2) testing because they have a personal history of a primary solid tumor other than basal or squamous cell skin cancer and risk assessment using Tyrer-Cuzick, BRCAPro, or Penn II calculators demonstrates a 2.5% or greater likelihood of a BRCA pathogenic variant; the patient has not undergone prior genetic testing and no pre-test genetic counseling was completed, and family history is notable for a mother with a persistent, severe hematologic or immunologic disorder, with testing being pursued with coverage through Cigna and results to be reviewed by the oncology team to inform management.",626eac4d60df057ea93ece78f8cc3dfc,Cigna_MOL.TS_.238.A_BRCA_Analysis_eff01.01.2025_pub09.10.2024_1.pdf,BRCA1/2,Yes,Not Specified,Not Specified,Not Specified,No,No,81162,No,626eac4d60df057ea93ece78f8cc3dfc
Case6747,"A 12-year-old child with multiple congenital anomalies is undergoing whole genome sequencing (WGS) ordered by the medical geneticist to evaluate a suspected genetic etiology. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic. The family reports a sibling with developmental delay, pre-test counseling has been completed and post-test counseling is planned, and the patient has coverage through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WGS,Yes,Not Specified,Yes,Yes,Yes,Yes,Not Specified,Yes,d5e9701c13de1dca302ad0ce45524039
Case15820,"The patient is a 31-year-old adult followed by neurology for developmental delay and intellectual disability without a suspected specific syndrome, and chromosomal microarray (CMA) has been ordered to evaluate for underlying copy number variants; no prior genetic testing has been reported, and the patient has completed multiple pre-test counseling sessions with a genetic counselor with plans for post-test follow-up, with insurance coverage through Cigna, and a pertinent family history of a mother who was diagnosed with breast cancer before age 50.",dd74cd39fca15b7b0888b16ce1da2014,Cigna_MOL.TS_.150A_CMA_for_Developmental_Disorders_and_Prenatal_Diagnosis_eff01.01.2025_pub09.10.2024_1.pdf,CMA,No,Not Specified,Yes,No,No,No,81228,No,dd74cd39fca15b7b0888b16ce1da2014
Case7447,"At 33 weeks' gestation, fetal imaging raises concern for an isolated severe congenital heart defect and the cardiologist has ordered whole genome sequencing (WGS) to evaluate for a possible genetic etiology and to guide postnatal management; prior fragile X testing was nondiagnostic, family history is notable for a maternal aunt with triple-negative breast cancer, there is no documentation of pre-test genetic counseling, and coverage is through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WGS,No,Not Specified,Yes,Yes,No,No,Not Specified,No,d5e9701c13de1dca302ad0ce45524039
Case18257,"The 64-year-old patient has a history of breast cancer diagnosed at age 50 or younger and is being evaluated for BRCA1/2 testing to assess hereditary breast and ovarian cancer risk. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic, family history is notable for a sibling with short stature, the test was ordered by the patient's general practitioner, there is no documentation of prior genetic counseling, and coverage is through Cigna.",626eac4d60df057ea93ece78f8cc3dfc,Cigna_MOL.TS_.238.A_BRCA_Analysis_eff01.01.2025_pub09.10.2024_1.pdf,BRCA1/2,Yes,Not Specified,Yes,Not Specified,No,No,81162,No,626eac4d60df057ea93ece78f8cc3dfc
Case17196,"The patient is a 63-year-old referred by the oncologist for chromosomal microarray (CMA) testing to evaluate a longstanding neuropsychiatric presentation with features suggestive of bipolar disorder, schizophrenia, or obsessive-compulsive disorder. Previous karyotype testing was nondiagnostic. The family history is notable for a sibling who had significant hearing or visual impairment diagnosed by age 18. No pre-test genetic counseling has been conducted and the test is being requested with coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS FEP).",8340e5b0ce4959eccfb2cb295edb47f3,BCBS_FEP_20459 Genetic Testing for Developmental.pdf,CMA,Not Specified,Not Specified,No,Not Specified,No,Not Specified,Not Specified,No,8340e5b0ce4959eccfb2cb295edb47f3
Case14017,"An otherwise healthy 7-week-old infant is being evaluated by the general pediatrician for a high-risk brief resolved unexplained event (BRUE) with recurrent witnessed seizure-like events, and whole exome sequencing (WES) has been ordered to evaluate for a possible genetic etiology. Prior karyotype testing was nondiagnostic. There is a family history of neurologic disease, specifically a maternal uncle reported to have a movement disorder with dystonia and ataxia, and pre-test genetic counseling was completed with plans for post-test follow-up. Testing is being pursued with coverage through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WES,Yes,Not Specified,Yes,Yes,Not Specified,Yes,Not Specified,Yes,d5e9701c13de1dca302ad0ce45524039
Case5230,"The 15-year-old adolescent was referred by neurology for whole exome sequencing (WES) to evaluate a congenital anomaly after a nondiagnostic chromosomal microarray (CMA). There is a family history of an inborn error of metabolism in a sibling, the patient has coverage through UHC, and genetic counseling was declined at this time.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Yes,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case15202,"The patient is a 65-year-old woman with a history of malignant phyllodes tumors of the breast who was referred by her gynecologist for BRCA1 and BRCA2 testing to evaluate possible hereditary breast and ovarian cancer risk, and she reports a sister with a persistent and severe immunologic or hematologic disorder in the family; Fragile X testing was previously performed and was nondiagnostic, pre-test counseling was completed with a genetic specialist with plans for post-test follow-up, and she has coverage through BCBS_FEP.",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf,BRCA1/2,Yes,Not Specified,No,Not Specified,No,No,Not Specified,No,c5c2b854957d06467835e88a963d0c82
Case15834,"The infant is being evaluated for concern for autism spectrum disorder based on early signs and was referred by the primary care physician for genetic assessment; whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology, and prior Fragile X testing was nondiagnostic. There is a family history of a maternal aunt with a congenital anomaly. Pre-test counseling was completed with a genetic specialist and testing will be pursued with coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,No,Yes,Yes,Yes,Not Specified,81415,No,4fadf6b3ca9d4d08131cb31365e3aa7d
Case14155,"The child is a 7-year-old referred by neurology for evaluation of autism spectrum disorder and whole genome sequencing (WGS) has been requested to assess for genetic contributors to the neurodevelopmental presentation. There is a family history notable for a maternal uncle with a persistent, severe immunologic disorder, which raised concern for an inherited predisposition that might overlap with neurodevelopmental features. There has been no prior genetic testing, and pre-test genetic counseling was declined by the family; testing is being pursued with coverage through Cigna.",36bb5264dda1b2027dcdfdd32a714204,Cigna_MOL.TS_.306.C_Whole_Genome_Sequencing_Cigna_eff01.01.2025_pub09.10.2024.pdf,WGS,Yes,Not Specified,Yes,No,No,Not Specified,81425,No,36bb5264dda1b2027dcdfdd32a714204
Case18882,"An 8-year-old child is referred by a developmental pediatrician for evaluation of multiple congenital anomalies affecting several organ systems, and whole exome sequencing (WES) is being requested with coverage through UHC; prior fluorescent in situ hybridization (FISH) testing was nondiagnostic, the family reports that the mother has long QT syndrome, and the family declined pre-test genetic counseling but agreed to proceed with testing with plans to coordinate post-test counseling to review results and management.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Not Specified,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case2666,"A 21-year-old woman with a major congenital cardiac anomaly is undergoing BRCA1/2 testing at the request of her obstetrician, and prior fluorescence in situ hybridization (FISH) testing was nondiagnostic; she reports a father with metastatic prostate cancer prompting consideration of hereditary cancer evaluation, pre-test counseling was completed with a genetic specialist and plans for post-test follow-up are in place, and she has coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",c5c2b854957d06467835e88a963d0c82,BCBS_FEP_20402 Germline Genetic Testing for.pdf,BRCA1/2,Yes,Not Specified,No,Not Specified,Yes,No,Not Specified,No,c5c2b854957d06467835e88a963d0c82
Case15557,"A 15-year-old referred by neurology for evaluation of a congenital anomaly present since birth is being evaluated with whole genome sequencing (WGS) to identify an underlying genetic etiology, and prior fluorescent in situ hybridization (FISH) testing was nondiagnostic; the patient has a sibling with a similar congenital anomaly and has been seen by a genetic counselor multiple times with plans for post-test counseling and coordination of care, and testing is being pursued with coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WGS,Yes,Yes,Yes,Yes,Yes,Not Specified,81425,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case3592,"The patient is a neonate evaluated by a developmental pediatrician for unexplained epileptic encephalopathy with neonatal onset and no prior epilepsy multigene panel testing; chromosomal microarray (CMA) testing for developmental disorders is being requested. A prior chromosomal microarray was nondiagnostic. There is a family history of an older sibling with unexplained developmental regression unrelated to autism or epilepsy. Pre-test counseling was discussed with a genetic specialist and post-test follow-up is planned, and testing is being submitted with coverage through Cigna.",dd74cd39fca15b7b0888b16ce1da2014,Cigna_MOL.TS_.150A_CMA_for_Developmental_Disorders_and_Prenatal_Diagnosis_eff01.01.2025_pub09.10.2024_1.pdf,CMA,Yes,Not Specified,No,No,No,No,81228,No,dd74cd39fca15b7b0888b16ce1da2014
Case6478,"A 52-year-old man with metastatic prostate cancer is being referred by his general practitioner for germline BRCA1 and BRCA2 testing because of a family history notable for a father with pancreatic cancer; he has had no prior genetic testing, pre-test genetic counseling was not completed, and testing is being pursued with coverage through UHC to inform therapeutic options and cascade testing for at-risk relatives with plans for post-test counseling and oncology follow-up once results are available.",c69485372670ce1d12aa8f61d83a06fd,United Healthcare_genetic-testing-hereditary-cancer.pdf,BRCA1/2,Yes,Not Specified,Yes,Not Specified,Yes,Not Specified,81162,Yes,c69485372670ce1d12aa8f61d83a06fd
Case3474,"The patient is a 5-year-old who was evaluated by a medical geneticist for congenital choanal atresia and whole genome sequencing (WGS) is being ordered to assess for an underlying genetic etiology or syndromic association given the structural airway anomaly and a reported older sibling with developmental delay, prior karyotype testing was nondiagnostic, pre-test genetic counseling has been completed on multiple occasions with plans for post-test follow-up, and testing is being pursued with coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WGS,Yes,Yes,Yes,Yes,Yes,Not Specified,81425,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case13,"The newborn is being evaluated by the general pediatrician for multiple congenital anomalies that do not fit a well-delineated genetic syndrome and has been referred for whole exome sequencing (WES) after karyotype testing was nondiagnostic, there is a family history of a sibling with unexplained developmental regression unrelated to autism or epilepsy, pre-test genetic counseling was completed and post-test follow-up is planned, and testing will be submitted with coverage through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WES,Yes,Not Specified,Yes,Yes,Yes,Yes,Not Specified,Yes,d5e9701c13de1dca302ad0ce45524039
Case8288,"Fetal imaging at 36 weeks' gestation is concerning for a major congenital cardiac anomaly and the pregnancy was referred by a developmental pediatrician for genetic evaluation. A chromosomal microarray (CMA) was previously performed and was nondiagnostic. There is a family history of an inborn error of metabolism affecting an older sibling, and the parents have had multiple sessions with a genetic counselor. Given the late-gestation identification of a significant cardiac malformation and the nondiagnostic CMA, whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology that could inform perinatal and postnatal management, with coverage through UHC noted.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Yes,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case9773,"The two-year-old is undergoing evaluation for severe intellectual disability with chromosomal microarray (CMA) ordered to assess for genomic copy number changes; there is no prior genetic testing on record. The study was ordered by the child's oncologist given concern for an underlying genetic etiology and there is a family history of a maternal aunt with a persistent and severe immunologic disorder. The family has coverage through the Blue Cross Blue Shield Federal Employee Program (FEP), and they completed pre-test genetic counseling with plans to return for post-test counseling after results are available.",8340e5b0ce4959eccfb2cb295edb47f3,BCBS_FEP_20459 Genetic Testing for Developmental.pdf,CMA,Not Specified,Not Specified,Yes,Not Specified,No,Not Specified,Not Specified,No,8340e5b0ce4959eccfb2cb295edb47f3
Case19162,"The infant is a neonate presenting with complex neurologic abnormalities including dystonia, ataxia, and asymmetric weakness suggestive of neonatal hemiplegia and was referred by a medical geneticist for whole genome sequencing (WGS) to evaluate for an underlying genetic or metabolic cause. Fragile X testing was previously performed and was nondiagnostic, and there is a family history of an inborn error of metabolism in a sibling. Pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, and testing will be pursued with coverage through BCBS_FEP.",d5e9701c13de1dca302ad0ce45524039,BCBS_FEP_204102 Whole Exome and.pdf,WGS,Yes,Not Specified,Yes,Yes,Yes,Yes,Not Specified,Yes,d5e9701c13de1dca302ad0ce45524039
Case19321,"The patient is a 1-year-old referred by a neurologist for evaluation of a complex neurodevelopmental disorder with features concerning for autism spectrum disorder, and whole exome sequencing (WES) is being pursued to investigate a possible genetic etiology; prior chromosomal microarray (CMA) testing was nondiagnostic. A maternal aunt is reported to have multiple congenital anomalies, pre-test genetic counseling was completed, and plans are in place for post-test follow-up, with coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,Yes,Yes,Yes,Yes,Yes,Not Specified,81415,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
Case9978,"The 53-year-old patient is undergoing whole exome sequencing (WES) at the request of the neurologist to evaluate an epileptic encephalopathy that began before age three and has persisted into adulthood; Fragile X testing was previously performed and was nondiagnostic. The patient has a brother with an inborn error of metabolism, has coverage through UHC, and completed pre-test counseling with a genetic counselor with plans for post-test follow-up.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WES,No,Yes,Yes,Yes,Yes,Not Specified,81415,No,4fadf6b3ca9d4d08131cb31365e3aa7d
Case10427,"An 8-week-old infant was referred by a neurologist for evaluation of significant hypotonia, and whole genome sequencing (WGS) is being requested to identify a potential genetic etiology; fluorescence in situ hybridization (FISH) testing was previously performed and was nondiagnostic. The family history is notable for an older sibling who experienced unexplained developmental regression not related to autism or epilepsy. Pre-test counseling has been completed with a genetic counselor on multiple occasions and post-test follow-up is planned, and testing is being ordered with coverage through UHC.",4fadf6b3ca9d4d08131cb31365e3aa7d,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,WGS,Yes,Yes,Yes,Yes,Yes,Not Specified,81425,Yes,4fadf6b3ca9d4d08131cb31365e3aa7d
